Feb 29 |
Fennec Pharmaceuticals reports Preliminary Unaudited Q4 results
|
Feb 29 |
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
|
Feb 1 |
FDA Issues Reminder of Non-Substitution of PEDMARKĀ® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
|
Jan 6 |
Insider Sell: CFO Robert Andrade Sells 30,000 Shares of Fennec Pharmaceuticals Inc
|
Dec 6 |
With 31% stake, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) seems to have captured hedge funds investors' interest
|
Nov 10 |
Fennec files $90M common shares offering
|
Nov 9 |
Fennec Pharmaceuticals Expands Possible TAM Significantly
|
Nov 9 |
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
|
Nov 7 |
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript
|
Nov 7 |
Q3 2023 Fennec Pharmaceuticals Inc Earnings Call
|